@ramad @Flaviker
Ramad, I am deferring my respect to you. I am also defending Flaviker. You seem to have the professional background and firsthand insights to what is happening behind the scenes with Echo. Without your information, I more than likely would have purchased more share at these "bargain prices." I thank you for this!
I am defending Flaviker because English is not his first language, Spanish is his native tongue. Of all of the Ramads, you can communicate in English very well. I don't know why Flaviker thinks that issuing more shares is the answer? But, it his opinion and we should respect his point of view.
I believe that most of understanding that financing is the issue. Compound lack of funds with the grip that the note holders have Echo's assets and technology, the shareholders are between the proverbial rock and a hard place! Financing or a partnership are the only answers! According to published clinical trials, Echo's technology works and only needs more R&D in the hands of competent technicians and businessmen.